The majority of liver cancer cases could be prevented by reducing levels of viral hepatitis, alcohol consumption and MASLD ...

Strong efficacy and cardiovascular benefits should allow Novo to continue growing sales of GLP-1 therapies in diabetes. Ozempic and Rybelsus helped Novo gain share over Eli Lilly's once-weekly ...

Six of every 10 liver cancers diagnosed globally are preventable through reduction of risk factors, a “conservative calculation” of cases projected until 2050 has concluded.1 The Lancet commission on ...

Experts call for urgent global action on hepatitis, alcohol, and obesity as new data shows that while preventable liver ...

DURECT's lead asset, Larsucosterol, is an epigenetic modulator with FDA Breakthrough Therapy Designation Potential to be the first FDA-approved therapeutic option for the treatment of ...

IT often strikes without symptoms until it’s too late – but spotting the early red flags of liver cancer could save your life ...

DURECT's lead asset, Larsucosterol, is an epigenetic modulator with FDA Breakthrough Therapy DesignationPotential to be the first FDA-approved therapeutic option for the treatment of patients with alc ...

At least 60% of liver cancers globally are preventable through risk-factor reduction, including obesity-linked metabolic ...

A recent Lancet Commission report has issued a stark warning: nearly 60 per cent of liver cancer cases globally are preventable if modifiable lifestyle risk factors such as hepatitis B and C ...

More than 60 per cent of liver cancer cases globally are due to preventable risk factors, with obesity-linked cases on the ...

A new Lancet study warns liver cancer deaths may nearly double by 2050. Experts say three in five cases can be prevented with hepatitis vaccination, reduced alcohol use, and tackling obesity.

Report pitches for Hepatitis vaccination, regular screening for those at risk, public awareness and strict curbs on alcohol ...